Analyze Diet
Veterinary parasitology1992; 41(3-4); 255-284; doi: 10.1016/0304-4017(92)90086-o

Critical and controlled tests of activity of moxidectin (CL 301,423) against natural infections of internal parasites of equids.

Abstract: The activity of moxidectin was evaluated in 1988 and 1989 against natural infections of internal parasites in 20 critical tests (n = 20 equids) and three controlled tests (n = 20 equids). Two formulations, injectable administered intramuscularly (i.m.) or intraorally (i.o.) and gel i.o., were given at dose rates of 0.2, 0.3 or 0.4 mg kg-1 body weight. For the critical tests (all three dose rates evaluated), removals of second instar Gasterophilus intestinalis were 93-100%, except (89%) for the injectable formulation (i.m.) at 0.2 mg kg-1. Removals of third instar G. intestinalis were 88-100% for the injectable formulation given i.m. or i.o. and 93-100% for the gel formulation, except (53%) for one batch (0.4 mg kg-1). Activity was 100% for third instar Gasterophilus nasalis, Parascaris equorum, Strongylus vulgaris and Strongylus edentatus. For Oxyuris equi, removals were 91-100%, except (27%) for one batch of the injectable formulation given i.o. at 0.3 mg kg-1. There was apparent activity against migrating S. vulgaris and S. edentatus at various dose rates and routes of administration for both formulations. At necropsy, there were local reactions observed at the injection site of three equids. In the controlled tests, dose rates were 0.2 or 0.4 mg kg-1. Removal of third instar G. intestinalis was highest for the injectable formulation given i.m. All formulations and dose rates were highly effective against S. vulgaris and S. edentatus, but variable and incomplete against O. equi. Removal was excellent on Habronema muscae and on migrating S. vulgaris and S. edentatus, although incomplete on S. vulgaris. Gasterophilus nasalis third instars and P. equorum were present in low numbers in some non-treated equids, but none were recovered from treated equids. Toxicosis was not evident.
Publication Date: 1992-03-01 PubMed ID: 1502789DOI: 10.1016/0304-4017(92)90086-oGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research evaluated the effectiveness of moxidectin, a medication, in treating internal parasites in horses, using both critical and controlled testing methods. Different forms of moxidectin and dose levels were tested, with results indicating effectiveness against a variety of parasites, though the rate of success varied.

Methodology and Testing Procedure

  • The tests were conducted in 1988 and 1989 using 40 horses in total. These were divided into 2 groups: one for critical tests and another for controlled tests, both including 20 horses each.
  • Two different formulations of moxidectin were utilized: one as an injectable form for intramuscular or oral administration, and the other as an oral gel.
  • The dose rates applied were 0.2, 0.3, or 0.4 mg per kilogram of body weight.
  • The parasites treated with moxidectin included Gasterophilus intestinalis, Gasterophilus nasalis, Parascaris equorum, Strongylus vulgaris, Strongylus edentatus, and Oxyuris equi.

Test Results

  • Removal rates for second instar G. intestinalis were 93-100%, although one batch of the injectable formulation yielded an 89% removal rate.
  • For third instar G. intestinalis, G. nasalis, P. equorum, S. vulgaris and S. edentatus, the efficiency rate reached 100%.
  • The only inconsistent results were noted for O. equi, with efficiency ranging from 27% to 100% depending on the formulation and dose rate.
  • There were also local reactions observed at the injection site in three horses.
  • No signs of toxicosis were noted in any of the horses.

Controlled Test Results

  • In the controlled tests, dosage rates of 0.2 or 0.4 mg per kilogram of body weight were applied.
  • The injectable formulation exhibited the highest removal rate of third instar G. intestinalis.
  • Discrepant and incomplete effects were observed against O. equi using this method.
  • Excellent removal rates were seen for Habronema muscae and migrating S. vulgaris and S. edentatus, although the treatment remained incomplete for S. vulgaris.
  • Treatment was highly effective against S. vulgaris and S. edentatus, and cleared G. nasalis third instars and P. equorum completely in treated horses.

Cite This Article

APA
Lyons ET, Tolliver SC, Drudge JH, Granstrom DE, Collins SS, Stamper S. (1992). Critical and controlled tests of activity of moxidectin (CL 301,423) against natural infections of internal parasites of equids. Vet Parasitol, 41(3-4), 255-284. https://doi.org/10.1016/0304-4017(92)90086-o

Publication

ISSN: 0304-4017
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 41
Issue: 3-4
Pages: 255-284

Researcher Affiliations

Lyons, E T
  • Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington 40546-0099.
Tolliver, S C
    Drudge, J H
      Granstrom, D E
        Collins, S S
          Stamper, S

            MeSH Terms

            • Administration, Oral
            • Animals
            • Anthelmintics / administration & dosage
            • Anthelmintics / therapeutic use
            • Anti-Bacterial Agents / administration & dosage
            • Anti-Bacterial Agents / therapeutic use
            • Female
            • Gels
            • Horse Diseases / drug therapy
            • Horses
            • Injections, Intramuscular / veterinary
            • Intestinal Diseases, Parasitic / drug therapy
            • Intestinal Diseases, Parasitic / veterinary
            • Macrolides
            • Male
            • Parasitic Diseases / drug therapy
            • Parasitic Diseases, Animal

            Citations

            This article has been cited 5 times.
            1. Cain JL, Nielsen MK. The equine ascarids: resuscitating historic model organisms for modern purposes. Parasitol Res 2022 Oct;121(10):2775-2791.
              doi: 10.1007/s00436-022-07627-zpubmed: 35986167google scholar: lookup
            2. Molena RA, Peachey LE, Di Cesare A, Traversa D, Cantacessi C. Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK Thoroughbreds. Parasit Vectors 2018 Jan 25;11(1):61.
              doi: 10.1186/s13071-018-2638-6pubmed: 29370872google scholar: lookup
            3. Zhang Z, Yu J, Song X, Gu Q, Zhang Y, Xue J, Moshin A, Wang Y, Wang Z. Mechanistic insights into ammonium-driven metabolic regulation for enhanced nemadectin biosynthesis in Streptomyces cyaneogriseus. Bioresour Bioprocess 2026 Jan 30;13(1):20.
              doi: 10.1186/s40643-026-01015-6pubmed: 41615585google scholar: lookup
            4. Šarkūnas M, Schwahn A, Suleimanova K. A pilot study on the potency of injectable vs. oral moxidectin formulation to suppress strongyle egg excretion in horses at twice lower dose. Helminthologia 2025 Jun;62(2):87-94.
              doi: 10.2478/helm-2025-0018pubmed: 41058774google scholar: lookup
            5. Nielsen MK. Anthelmintic resistance in equine nematodes: Current status and emerging trends. Int J Parasitol Drugs Drug Resist 2022 Dec;20:76-88.
              doi: 10.1016/j.ijpddr.2022.10.005pubmed: 36342004google scholar: lookup